第六节 预防控制
已知MERS是一种致死性很高的人兽共患疾病,疫苗靶点为可进入细胞且可产生中和反应的S蛋白。但目前研制的疫苗除了小鼠试验有效外,还没有一种商业化人用疫苗研制出来; 至2016年止,只有DNA疫苗已进行Ⅰ期临床试验,其他4类(减毒、亚单位及重组载体疫苗等)约12种候选疫苗均处于临床前研究阶段;目前认为用改造的MVA病毒载体及黑猩猩腺病毒载体用于MERS疫苗的研制较为合适。有人则认为MERS是散发性传染病,单峰骆驼是直接或间接的传染源,只要简单的研制兽用疫苗阻断MERS-CoV的传播就可达到防制目的。Haagmans 等用改良的活病毒疫苗(MVA)载体携MERS-CoV S蛋白基因经黏膜途径免疫单峰骆驼,发现该候选苗可以产生抗MERS-CoV的中和抗体,并可减少呼吸道感染性病毒,使所试骆驼症状减轻。
在人用疫苗未诞生之前,WHO则建议采用非药物干预方式预防 MERS-CoV的传播,其中减少动物-人的传播、快速识别病例、追踪在医疗机构与确诊病例有关的所有密切接触者以及采取控制 MERS-CoV 感染的核心措施。就一般性防护而言,应加强对旅游者有针对性的宣传教育,前去参观有单峰骆驼和其他动物的农场、市场、饲料仓或其他可能存在感染性地域的人员应当采取一般性个人卫生措施,包括尽可能避免与动物的接触,接触动物前后应彻底洗手。除此之外,禁食未煮熟的骆驼肉或生骆驼奶。
(王晓欢 严延生)
参考文献
[1]Zaki AM,Van BS,Bestebroer TM,et al.Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J].N Engl J Med,2012,367(19):1814-1820.DOI:10.1056/NEJMoa1211721.
[2]Cotten M,Watson SJ,Kellam P,et al.Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia:a descriptive genomic study[J].Lancet,2013,382(9909):1993-2002.
[3]Cotten M,Watson S J,Zumla A I,et al.Spread,circulation,and evolution of the Middle East respiratory syndrome coronavirus[J].Mbio,2014,5(1):245-256.
[4]Cui J,Li F,Shi ZL.Origin and evolution of pathogenic coronaviruses[J].Nat Rev Microbiol,2019,17(3):181-192.DOI:10.1038/s41579-018-0118-9.
[5]Wernery U,Lau SK,Woo PC.Genomics and zoonotic infections:Middle East respiratory syndrome[J].Rev Sci Tech,2016,35:191-202.
[6]Lu R,Wang Y,Wang W,et al.Complete genome sequence of Middle East respiratory syndrome Coronavirus (MERS-CoV)from the first imported MERS-CoV case in China[J].Genome Announc,2015,3.
[7]CorWidagdo W,Raj VS,Schipper D,et al.Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels[J].J Virol,2016,90:4838-4842.
[8]Letko M,Miazgowicz K,McMinn R,et al.Adaptive evolution of MERS-CoV to species variation in DPP4[J].Cell Rep,2018,24(7):1730-1737.DOI:10.1016/j.celrep.2018.07.045.
[9]Chafekar A,Fielding BC.MERS-CoV:Understanding the latest human Coronavirus threat[J].Viruses,2018,10(2):93.DOI:10.3390/v10020093.
[10]World Health Organization.Middle East respiratory syndrome coronavirus (MERSCoV).https://www.who.int/emergencies/mers-cov/en/.
[11]World Health Organization.Middle East respiratory syndrome coronavirus(MERS-CoV)[DB/OL].http://www.emro.who.int/health-topics/mers-cov/situation-update.html.
[12]Tyrel DA,Bynoe ML.Cultivation of a novel type of common cold virus in organ culture[J].Br Med J,1965,1(5448):1467-1470.DOI:10.1136/bmj.1.5448.1467.
[13]De Benedictis P,Marciano S,Scaravelli D,et al.Al-pha and lineage C betaCoV infections in Italian bats[J].Virus Genes,2014,48:366-371.DOI:10.1007/s11262-013-1008.
[14]Wacharapluesadee S,Sintunawa C,Kaewpom T,et al.Group C betacorona-virus in bat guano fertilizer,Thailand[J].Emerg Infect Dis,2013,19:1349-1351.DOI:10.3201/eid1908.130119.
[15]Ge XY,Li JL,Yang XL,et al.Isolation and characterization of a bat SARSlike coronavirus that uses the ACE2 receptor[J].Nature,2013,503:535–538.DOI:org/10.1038/nature12711.
[16]Annan A,Baldwin HJ,Corman VM,et al.Human betacoronavirus 2c EMC/2012-related viruses in bats,Ghana and Europe[J].Emerg Infect Dis,2013,19:456.DOI:10.3201/eid1903.121503.(https://www.daowen.com)
[17]Memish ZA,Mishra N,Olival KJ,et al.Middle East respiratory syndrome coronavirus in bats,Saudi Arabia[J].Emerg Infect Dis,2013,19:1819.DOI:10.3201/eid1911.131172.
[18]Reusken CB,Haagmans BL,Muller MA,et al.Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels:a comparative serological study[J].Lancet Infect Dis,2013,13:859-866.DOI:10.1016/S1473-3099(13)70164-6.
[19]Haagmans BL,Al Dhahiry SHS,Reusken CBEM,et al.Middle East respiratory syndrome coronavirus in dromedary camels:an outbreak investigation[J].Lancet Infect Dis,2013,14:140-145.DOI:10.1016/S1473-3099(13)70690-X.
[20]Azhar EI,El-Kafrawy SA,Farraj SA,et al.Evidence for camel-to-human transmission of MERS coronavirus[J].N Engl J Med,2014,370:2499-505.DOI:10.1056/NEJMoa1401505.
[21]Müller MA,Meyer B,Corman VM,et al.Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia:a nationwide,cross-sectional,serological study.Lancet Infect Dis.2015;15:559–564.DOI:10.1016/S1473-3099(15)70090-3.
[22]Alraddadi BM,Watson JT,Almarashi A,et al.Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans,Saudi Arabia,2014[J].Emerg Infect Dis,2016.DOI:10.3201/eid2201.151340.
[23]Alagaili AN,Briese T,Mishra N,et al.Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia[J].mBio,2014,5:e0088400814.DOI:10.1128/mBio.00884-14.
[24]Meyer B,Müller MA,Corman VM,et al.Antibodies against MERS coronavirus in dromedary camels,United Arab Emirates,2003 and 2013[J].Emerg Infect Dis,2014,20(4):552-559.DOI:10.3201/eid2004.131746.
[25]Reusken CBEM,Messadi L,Feyisa A,et al.Geographic distribution of MERS coronavirus among dromedary camels,Africa[J].Emerg Infect Dis,2014.DOI:10.3201/eid2008.140590.
[26]Reusken CBEM,Farag EABA,et al.Occupational exposure to dromedaries and risk for MERS-CoV infection,Qatar,2013–2014[J].Emerg Infect Dis,2015,21(8):1422-1425.DOI:10.3201/eid2108.150481.
[27]Adney DR,van Doremalen N,Brown VR,et al.Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels[J].Emerg Infect Dis,2014,20:1999-2005.DOI:10.3201/eid2012.141280.
[28]Ro JS,Lee JS,Kang SC,et al.Worry experienced during the 2015 Middle East Respiratory Syndrome (MERS)pandemic in Korea[J].PLoS One,2017,12(3):e0173234.DOI:10.1371/journal.pone.0173234.
[29]Centers for disease control and prevention .MERS Clinical Features[DB/OL].https ://www .cdc .gov/coronavirus/mers/clinical-features .html.
[30]Mustafa S,Balkhy H,Gabere MN.Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS):A review.J Infect Public Health.2018;11(1):9–17.DOI:10.1016/j.jiph.2017.08.009.
[31]World Health Organization.Laboratory Testing for Middle East Respiratory Syndrome Coronavirus[EB/OL].https://apps.who.int/iris/bitstream/handle/10665/259952/WHO-MERSLAB-15.1-Rev1-2018-eng.pdf;jsessionid=29102037B8AB84C9B71467.
[32]武桂珍.中东呼吸综合征(MERS-CoV)实验室生物安全[EB/OL].(2016-05-04)[2020-05-01].https://wkretype.bdimg.com/retype/zoom/12056765561252d380eb6ef9pn=1&o=jpg_6&md5s.
[33]Haagmans BL,van den Brand JM,Raj VS,et al.An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels[J].Science,2016,351(6268):77-81.DOI:10.1126/science.aad1283.
[34]World Health Organization.Middle East respiratory syndrome coronavirus (MERSCoV)[EB/OL].http://www.who.int/news-room/fact-sheets/detail/middle-east-respiratorysyndrome-coronavirus-(mers-cov).
[35]Song Z,Xu Y,Bao L,et al.From SARS to MERS,Thrusting Coronaviruses into the Spotlight.Viruses.2019.11(1):59.doi:10.3390/v11010059.PMID:30646565;PMCID:PMC6357155.